Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cc100 (2 trials)
Amyotrophic Lateral Sclerosis (Phase 1)
Motor Neuron Disease (Phase 1)
Trials (2 total)
Trial APIs (1 total)